Summary#
This bill reauthorizes and updates several federal programs that support newborn screening for heritable disorders. It updates program purposes and approval factors, requires new consumer education materials, strengthens lab quality and national surveillance, changes research and ethics rules for dried blood spots, and increases authorized funding levels through 2030. It also updates the Hunter Kelly research program to require pilot testing of reliable newborn screening technologies and asks funded entities to consult State health departments "as practicable."
What it means for you#
- Parents and families: The bill directs creation and delivery of educational materials about screening, follow-up, and long-term care. It also calls for re-engaging people who missed recommended follow-up services.
- Health care providers and clinical labs: The bill emphasizes development of new screening tests, test performance materials, and lab performance evaluation services. It directs improved guidance on genetic testing for children with conditions that have varied genetic causes.
- State programs and public health agencies: The bill asks the CDC to coordinate national surveillance, standardize electronic data collection from initial positive screen through long-term care, and promote data linkages between newborn screening and state birth defects or developmental disability surveillance programs.
- Researchers and research review boards: The bill treats research on nonidentified newborn dried blood spots as secondary research under existing federal definitions and updates the Hunter Kelly research program to prioritize piloting reliable screening technologies and consultation with State health departments.
- Advisory Committee: The bill expands duties to publish consumer-friendly materials about the uniform screening panel nomination process, adopt process improvements, and clarify technical assistance and conflict-of-interest situations.
Expenses#
The bill amends existing authorization language to increase specific program funding levels. It replaces prior amounts with $20,883,000 (for one program line) and $22,250,000 (for another program line) and updates the covered years to 2026 through 2030. No publicly available information on overall budgetary effects beyond these authorized amounts.
Proponents' View#
No publicly available information.
Opponents' View#
No publicly available information.